Sarah Michelle Live Review Study Guide
– 185 Comprehensive Review
Questions & Answers for Nurse
Practitioner Certification Exam Prep
(PDF)
Unlock your success on the NP board exam with this comprehensive Sarah Michelle
Crash Course: 185+ Practice Questions & Detailed Rationales. This study guide is
specifically designed to reinforce high-yield concepts, sharpen your clinical reasoning,
and build the testing stamina you need to pass with confidence.
Master the Boards with Confidence
Are you preparing for your AANP or ANCC Nurse Practitioner certification? Don't just
memorize facts—master the application. This crash course package delivers the
ultimate practice toolkit, modeled directly after the style and complexity of the actual
board exams.
With over 185 premium practice questions, you will expose your weak areas, solidify
your strengths, and eliminate exam-day anxiety.
What is Included?
• 185+ High-Yield Questions: Comprehensive practice covering core clinical
conditions, pharmacology, assessment, and professional roles.
• Detailed Rationales: In-depth explanations for every correct and incorrect
answer so you understand the "why" behind the clinical choices.
• Sarah Michelle Style Mapping: Questions built around the signature, easy-to-
digest teaching style that has helped thousands of students pass.
Key Benefits
1
, • Identify Knowledge Gaps: Pinpoint exactly which systems or concepts need a
second look before test day.
• Learn Test-Taking Strategies: Master how to break down complex vignettes
and eliminate distractor options.
• Flexible, On-the-Go Study: Perfect for last-minute cramming or structured daily
quiz sessions.
Who is This For?
• FNP & AGNP Students preparing for their upcoming AANP or ANCC
certification exams.
• Repeat Test-Takers looking for a fresh, highly effective bank of questions to
break through to a passing score.
• Current Students wanting to get a head start on board-style questions during
their clinical rotations.
1. Contact Dermatitis
• Question: A patient presents with a linear, highly localized erythematous rash. What is
the most likely diagnosis and first-line treatment?
• Answer: Contact dermatitis; treated with topical corticosteroids.
• Rationale: Contact dermatitis is a type IV delayed hypersensitivity reaction resulting
from direct skin exposure to an allergen (like poison ivy, which classically creates a
linear distribution from brushing against the plant) or an irritant. Treatment focuses on
removing the offending agent and applying topical steroids to reduce localized
inflammation and pruritus.
2. Vesicular Lesions (Viral)
• Question: What is the critical therapeutic window for initiating antiviral therapy in a
patient presenting with acute, painful vesicular lesions?
• Answer: Within 48 to 72 hours of symptom onset.
• Rationale: Cutaneous viral infections characterized by vesicular clusters (such as Herpes
Simplex Virus or Varicella-Zoster Virus) require prompt intervention. Initiating antiviral
medications within 48 to 72 hours is vital because viral replication peaks early; treating
within this timeframe significantly shortens the duration of the illness, minimizes pain,
and decreases the risk of long-term complications like postherpetic neuralgia.
3. Chronic Ulcerative Stomatitis
2
, • Question: Which autoimmune oral condition presents with numerous large ulcers that
persist for weeks to months, fail to respond to standard topical corticosteroids, and
requires systemic immunomodulatory therapy?
• Answer: Chronic ulcerative stomatitis; treated with Hydroxychloroquine.
• Rationale: Chronic ulcerative stomatitis is a rare autoimmune mucosal disease
characterized by chronic, painful oral ulcerations. Unlike aphthous ulcers or erosive
lichen planus, these lesions are uniquely resistant to topical corticosteroids. The gold
standard for long-term management and resolution is systemic antimalarial therapy with
hydroxychloroquine.
4. Impetigo
• Question: A pediatric patient presents with honey-crusted lesions and dry yellow
drainage on the face. If the presentation is bullous and suspected to be Methicillin-
Resistant Staphylococcus aureus (MRSA), what is the appropriate oral antibiotic choice?
• Answer: Bullous Impetigo (MRSA); treated with oral Doxycycline.
• Rationale: Impetigo is a highly contagious superficial bacterial skin infection. Non-
bullous impetigo presents with classic honey-crusted lesions, whereas bullous impetigo
causes larger, fluid-filled blisters typically driven by Staphylococcus aureus exfoliative
toxins. When MRSA is suspected or confirmed in bullous presentations, oral doxycycline
is a highly effective treatment choice (indicated for patients older than 8 years).
5. Pityriasis Rosea
• Question: A patient presents with a single, large "herald patch" on the trunk, followed
days later by a diffuse, symmetric maculopapular rash distributed along cleavage lines in
a "Christmas tree" pattern. What is the expected clinical course?
• Answer: Pityriasis rosea; it is a self-limiting condition that usually resolves on its
own.
• Rationale: Pityriasis rosea is a benign, eruptive dermatosis thought to be linked to viral
exanthems (such as HHV-6 or HHV-7). It begins with an isolated primary plaque (herald
patch) and progresses to smaller oval lesions aligned along Langer’s lines (skin cleavage
lines). Because it is benign and self-limiting, active treatment is unnecessary unless
symptomatic relief for pruritus is required.
6. Brown Recluse Spider Bite
• Question: An individual presents with a painful skin lesion featuring a central necrotic
area surrounded by a distinct white halo and complains of systemic symptoms. What is
the suspected cause?
3
, • Answer: Brown recluse spider bite.
• Rationale: The bite of a brown recluse spider (Loxosceles reclusa) introduces cytotoxic
venom that triggers local tissue ischemia, characteristically forming a red, white, and blue
sign (a central violaceous area, a surrounding white ring of ischemia, and an outer ring of
erythema). Systemic symptoms—such as fever, chills, and myalgias—can occur
alongside focal necrotic arachnidism.
7. Vector-Borne Erythemas: Lyme Disease & Rocky Mountain Spotted
Fever (RMSF)
• Question: Compare the clinical presentations of Lyme disease and Rocky Mountain
Spotted Fever (RMSF), and identify the primary choice of antibiotic therapy for both.
• Answer: Lyme disease presents with a "bull's-eye" target lesion (Erythema
Migrans); RMSF presents with a petechial rash on the palms and soles 3–5 days
after a tick bite in endemic areas (e.g., North Carolina). Both are treated first-line
with Doxycycline (Amoxicillin is used for Lyme disease in pregnant patients).
• Rationale: Both conditions are tick-borne bacterial infections, but they manifest
differently. Erythema migrans is the hallmark expanding targetoid lesion of early
localized Lyme disease (Borrelia burgdorferi). RMSF (Rickettsia rickettsii) is a life-
threatening illness causing a rash that starts on the wrists and ankles—crucially involving
the palms and soles—before spreading centrally. Doxycycline is the absolute standard of
care for both due to its excellent intracellular penetration. Because tetracyclines pose fetal
risks, oral amoxicillin is the preferred alternative for pregnant patients with Lyme
disease.
8. Measles (Rubeola)
• Question: A child presenting with fever, cough, coryza, and conjunctivitis develops tiny,
white-sand-like spots on the buccal mucosa followed by a generalized maculopapular
rash. What are these oral spots called, and how is this disease prevented from recurring in
the population?
• Answer: Koplik spots; prevented by administering the MMR (Measles, Mumps, and
Rubella) vaccine at 12 months of age.
• Rationale: Measles is a highly contagious viral illness characterized by the "3 Cs"
(cough, coryza, conjunctivitis) and a prodromal exanthem. Koplik spots are
pathognomonic, presenting as small, bluish-white spots on an erythematous background
inside the cheeks before the systemic rash appears. Population immunity and individual
prevention rely on the two-dose MMR vaccine series, with the first dose administered
between 12 and 15 months of age.
4
– 185 Comprehensive Review
Questions & Answers for Nurse
Practitioner Certification Exam Prep
(PDF)
Unlock your success on the NP board exam with this comprehensive Sarah Michelle
Crash Course: 185+ Practice Questions & Detailed Rationales. This study guide is
specifically designed to reinforce high-yield concepts, sharpen your clinical reasoning,
and build the testing stamina you need to pass with confidence.
Master the Boards with Confidence
Are you preparing for your AANP or ANCC Nurse Practitioner certification? Don't just
memorize facts—master the application. This crash course package delivers the
ultimate practice toolkit, modeled directly after the style and complexity of the actual
board exams.
With over 185 premium practice questions, you will expose your weak areas, solidify
your strengths, and eliminate exam-day anxiety.
What is Included?
• 185+ High-Yield Questions: Comprehensive practice covering core clinical
conditions, pharmacology, assessment, and professional roles.
• Detailed Rationales: In-depth explanations for every correct and incorrect
answer so you understand the "why" behind the clinical choices.
• Sarah Michelle Style Mapping: Questions built around the signature, easy-to-
digest teaching style that has helped thousands of students pass.
Key Benefits
1
, • Identify Knowledge Gaps: Pinpoint exactly which systems or concepts need a
second look before test day.
• Learn Test-Taking Strategies: Master how to break down complex vignettes
and eliminate distractor options.
• Flexible, On-the-Go Study: Perfect for last-minute cramming or structured daily
quiz sessions.
Who is This For?
• FNP & AGNP Students preparing for their upcoming AANP or ANCC
certification exams.
• Repeat Test-Takers looking for a fresh, highly effective bank of questions to
break through to a passing score.
• Current Students wanting to get a head start on board-style questions during
their clinical rotations.
1. Contact Dermatitis
• Question: A patient presents with a linear, highly localized erythematous rash. What is
the most likely diagnosis and first-line treatment?
• Answer: Contact dermatitis; treated with topical corticosteroids.
• Rationale: Contact dermatitis is a type IV delayed hypersensitivity reaction resulting
from direct skin exposure to an allergen (like poison ivy, which classically creates a
linear distribution from brushing against the plant) or an irritant. Treatment focuses on
removing the offending agent and applying topical steroids to reduce localized
inflammation and pruritus.
2. Vesicular Lesions (Viral)
• Question: What is the critical therapeutic window for initiating antiviral therapy in a
patient presenting with acute, painful vesicular lesions?
• Answer: Within 48 to 72 hours of symptom onset.
• Rationale: Cutaneous viral infections characterized by vesicular clusters (such as Herpes
Simplex Virus or Varicella-Zoster Virus) require prompt intervention. Initiating antiviral
medications within 48 to 72 hours is vital because viral replication peaks early; treating
within this timeframe significantly shortens the duration of the illness, minimizes pain,
and decreases the risk of long-term complications like postherpetic neuralgia.
3. Chronic Ulcerative Stomatitis
2
, • Question: Which autoimmune oral condition presents with numerous large ulcers that
persist for weeks to months, fail to respond to standard topical corticosteroids, and
requires systemic immunomodulatory therapy?
• Answer: Chronic ulcerative stomatitis; treated with Hydroxychloroquine.
• Rationale: Chronic ulcerative stomatitis is a rare autoimmune mucosal disease
characterized by chronic, painful oral ulcerations. Unlike aphthous ulcers or erosive
lichen planus, these lesions are uniquely resistant to topical corticosteroids. The gold
standard for long-term management and resolution is systemic antimalarial therapy with
hydroxychloroquine.
4. Impetigo
• Question: A pediatric patient presents with honey-crusted lesions and dry yellow
drainage on the face. If the presentation is bullous and suspected to be Methicillin-
Resistant Staphylococcus aureus (MRSA), what is the appropriate oral antibiotic choice?
• Answer: Bullous Impetigo (MRSA); treated with oral Doxycycline.
• Rationale: Impetigo is a highly contagious superficial bacterial skin infection. Non-
bullous impetigo presents with classic honey-crusted lesions, whereas bullous impetigo
causes larger, fluid-filled blisters typically driven by Staphylococcus aureus exfoliative
toxins. When MRSA is suspected or confirmed in bullous presentations, oral doxycycline
is a highly effective treatment choice (indicated for patients older than 8 years).
5. Pityriasis Rosea
• Question: A patient presents with a single, large "herald patch" on the trunk, followed
days later by a diffuse, symmetric maculopapular rash distributed along cleavage lines in
a "Christmas tree" pattern. What is the expected clinical course?
• Answer: Pityriasis rosea; it is a self-limiting condition that usually resolves on its
own.
• Rationale: Pityriasis rosea is a benign, eruptive dermatosis thought to be linked to viral
exanthems (such as HHV-6 or HHV-7). It begins with an isolated primary plaque (herald
patch) and progresses to smaller oval lesions aligned along Langer’s lines (skin cleavage
lines). Because it is benign and self-limiting, active treatment is unnecessary unless
symptomatic relief for pruritus is required.
6. Brown Recluse Spider Bite
• Question: An individual presents with a painful skin lesion featuring a central necrotic
area surrounded by a distinct white halo and complains of systemic symptoms. What is
the suspected cause?
3
, • Answer: Brown recluse spider bite.
• Rationale: The bite of a brown recluse spider (Loxosceles reclusa) introduces cytotoxic
venom that triggers local tissue ischemia, characteristically forming a red, white, and blue
sign (a central violaceous area, a surrounding white ring of ischemia, and an outer ring of
erythema). Systemic symptoms—such as fever, chills, and myalgias—can occur
alongside focal necrotic arachnidism.
7. Vector-Borne Erythemas: Lyme Disease & Rocky Mountain Spotted
Fever (RMSF)
• Question: Compare the clinical presentations of Lyme disease and Rocky Mountain
Spotted Fever (RMSF), and identify the primary choice of antibiotic therapy for both.
• Answer: Lyme disease presents with a "bull's-eye" target lesion (Erythema
Migrans); RMSF presents with a petechial rash on the palms and soles 3–5 days
after a tick bite in endemic areas (e.g., North Carolina). Both are treated first-line
with Doxycycline (Amoxicillin is used for Lyme disease in pregnant patients).
• Rationale: Both conditions are tick-borne bacterial infections, but they manifest
differently. Erythema migrans is the hallmark expanding targetoid lesion of early
localized Lyme disease (Borrelia burgdorferi). RMSF (Rickettsia rickettsii) is a life-
threatening illness causing a rash that starts on the wrists and ankles—crucially involving
the palms and soles—before spreading centrally. Doxycycline is the absolute standard of
care for both due to its excellent intracellular penetration. Because tetracyclines pose fetal
risks, oral amoxicillin is the preferred alternative for pregnant patients with Lyme
disease.
8. Measles (Rubeola)
• Question: A child presenting with fever, cough, coryza, and conjunctivitis develops tiny,
white-sand-like spots on the buccal mucosa followed by a generalized maculopapular
rash. What are these oral spots called, and how is this disease prevented from recurring in
the population?
• Answer: Koplik spots; prevented by administering the MMR (Measles, Mumps, and
Rubella) vaccine at 12 months of age.
• Rationale: Measles is a highly contagious viral illness characterized by the "3 Cs"
(cough, coryza, conjunctivitis) and a prodromal exanthem. Koplik spots are
pathognomonic, presenting as small, bluish-white spots on an erythematous background
inside the cheeks before the systemic rash appears. Population immunity and individual
prevention rely on the two-dose MMR vaccine series, with the first dose administered
between 12 and 15 months of age.
4
